Virano Therapeutics
PrivateLast Round
Grant
Oct 23, 2025
Company Overview
Virano Therapeutics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in October 2025.
Virano Therapeutics is a biotechnology company that develops genetic immunomodulation products and combination therapies to treat solid tumors and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virano Therapeutics Comparables
Compare Virano Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRION Biotech | 73% | |
| Mediphage Bioceuticals | 72% | |
| Virica Biotech | 66% |
For institutional investors. Book with your work email.
Virano Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2025 | ||||
| Accelerator | Dec 3, 2024 | ||||
| Seed | Nov 20, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Virano Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Bioscience Innovation Organization | Grant |
| Capital BioVentures | Accelerator, Seed |
| AyaWas Group | Seed |
| FACIT | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 491% MoM, from 32 to 189.
- Dec 3, 2024
Received funding from Capital BioVentures.
For institutional investors. Book with your work email.
Virano Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Virano Therapeutics's valuation, stock price, and market status.
Is Virano Therapeutics a public or private company?
Virano Therapeutics is a private company.
What is the current stock price of Virano Therapeutics?
Virano Therapeutics is a private company, so its shares have no public market price. Caplight tracks Virano Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Virano Therapeutics worth (valuation)?
Valuation information for Virano Therapeutics is not publicly available.
Can I buy Virano Therapeutics stock?
Virano Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Virano Therapeutics's last funding round?
Virano Therapeutics's most recent funding round was Grant on October 23, 2025.
Who are the main investors in Virano Therapeutics?
Key investors in Virano Therapeutics include Ontario Bioscience Innovation Organization, Capital BioVentures, AyaWas Group, FACIT.
Will Virano Therapeutics IPO soon?
No public IPO plans have been announced for Virano Therapeutics.
How can I track Virano Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Virano Therapeutics's shares on secondary markets.